Coronavirus disease has taken world by storm. Currently, not even a single country is immune to this deadly disease. What has made the matters worse is the mental stress developed due to fear and anxiety of looming uncertainty. This may…


Apr 2, 2020 EMA has recommended that fosfomycin medicines given by infusion (drip) into a vein should only be used to treat serious infections when other antibiotic treatments are not suitable. Fosfomycin medicines given by mouth can continue to…

March 31, 2020 EMA has published its Regulatory Science Strategy to 2025 today. The strategy provides a plan for advancing regulatory science over the next five years, covering both human and veterinary medicines. It comes in response to the dramatic…

Coronavirus disease has taken world by storm. Currently, not even a single country is immune to this deadly disease. Till now, this deadly disease has taken lives of more than 35000 people and more than 750 thousand people are infected…

February 28, 2020 The U.S. Food and Drug Administration has approved an application for the first generic of Daraprim (pyrimethamine) tablets for the treatment of toxoplasmosis (an infection caused by the parasite Toxoplasma gondii) when used with a sulfonamide (a…
Recent Post
- CDSCO Introduces Online Process for Additional Variant Applications in Cosmetics
- India Imposes National Ban on Nimesulide for Veterinary Use Due to Toxicity Risks
- Major Relief for MSME Pharma Manufacturers: MoHFW Extends Deadline for Revised GMP Compliance
- Pharmacovigilance system compliance in India
- Simplifying Clinical Trial Amendment Approvals in India